Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation.
Fouillard
L
L
Serfaty
L
L
Gozlan
J
J
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006509:Hepatitis B / Q000150:complications*; D006515:Hepatitis B virus / Q000302:isolation & purification / Q000502:physiology*; D006801:Humans; D019259:Lamivudine; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000628:therapy*; D063065:Organophosphonates / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D019562:Viral Load; D014775:Virus Activation
D000970:Antineoplastic Agents; D063065:Organophosphonates; D019259:Lamivudine; C053001:adefovir; D000225:Adenine